Edwards Lifesciences Corporation (EW)

81.73 +0.65 (+0.80%) 收市價： 04:00PM EDT

Edwards Lifesciences Corporation

One Edwards Way
Irvine, CA 92614
United States
949 250 2500
https://www.edwards.com

版塊: Healthcare
行業: Medical Devices
全職員工: 17,300

高階主管

名稱	標題	支付	行使價	出生年份
Mr. Michael A. Mussallem	Chairman & CEO	2.88M	64.1M	1953
Mr. Scott B. Ullem	Corp. VP & CFO	1.32M	無	1967
Mr. Donald E. Bobo Jr.	Corp. VP of Strategy & Corp. Devel.	1.26M	11.63M	1962
Mr. Larry L. Wood	Corp. VP and Group Pres of TAVR & Surgical Structural Heart	1.31M	5.51M	1966
Mr. Jean-Luc Lemercier	Corp. VP of Europe, Middle East, Africa, Canada & Latin America	1.43M	4.89M	1957
Mr. Bernard J. Zovighian	Pres	無	無	1968
Dr. Todd J. Brinton	Corp. VP of Advanced Technology & Chief Scientific Officer	無	無	無
Mark Wilterding	VP of Investor Relations	無	無	無
Mr. Arnold A. Pinkston	Corp. VP & Gen. Counsel	無	無	1959
Mr. Dirksen J. Lehman	Corp. VP of Public Affairs	無	無	無

截止 2021年12月31日為止計算的金額，現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 USD。

描述

Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides the PASCAL and Cardioband transcatheter valve repair systems for minimally-invasive therapy. In addition, it offers surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; KONECT RESILIA, a pre-assembled aortic tissue valved conduit for patients who require replacement of the valve, root, and ascending aorta; and HARPOON Beating Heart Mitral Valve Repair System for patients with degenerative mitral regurgitation. Further, the company provides critical care solutions, including advanced hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.

公司管治

截至 2023年3月1日 止，Edwards Lifesciences Corporation 的 ISS 管治質素評分為 2。 Pillar 分數正在審核中：3；董事會：4；股東權利：4；現金賠償：4。

企業管治評分的資料提供： Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險，而 10 分表示較高的管治風險。